Nasal Flu Vaccines Provide 'Double' Immunity, Carrington Labs Says

Fri, 16 Feb 2007 02:00 PM EST

... Carrington Laboratories, Inc.'s (Nasdaq: CARN) DelSite Biotechnologies subsidiary, an innovator in nasal vaccine delivery technology, said flu vaccines delivered nasally have been shown to provide immunity both locally in the nasal passages and also systemically as the vaccine penetrates the nasal mucosa. [click link for full article] ...